Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that the Company will present 11 abstracts, including a late-breaking poster, at the upcoming American Society of Nephrology (ASN) Kidney Week ...
A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...